Anjali Jain
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anjali Jain has a total of 92 co-authors. Here are the top co-authors by number of shared publications:
- Robert Lesurf
Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada
3 shared publications - Seema Mital
Ted Rogers Centre for Heart Research, Toronto, Canada (T.P., S.M.).
3 shared publications - Erwin Oechslin
Toronto Adult Congenital Heart Disease Program, Division of Cardiology, Peter Munk Cardiac Centre, University Health Network, and University of Toronto, Toronto, Canada
2 shared publications - Jade Bouwmeester
Genetics and Genome Biology Program (R.L., A.M., Y.Y., V.A.K., J.W., T.P., R.K.C.Y., S.M.), The Hospital for Sick Children, Toronto, Canada
2 shared publications - Nour Hanafi
The Centre for Computational Medicine (A.J., N.H.), The Hospital for Sick Children, Toronto, Canada
2 shared publications - Tanya Papaz
Ted Rogers Centre for Heart Research, Toronto, Canada (T.P., S.M.).
2 shared publications
Latest Publications
- Open Access
- 13 May 2026
- Published by Springer Nature in Nature
- Vol. 655 (8122) , 418-428
An X-linked long non-coding RNA, PTCHD1-AS, and the core features of autism
There are around 100 genes or copy-number variations used in genetic testing for autism spectrum disorder (ASD)1,2. The established genes are protein coding, and the associated phenotypes usually extend beyond sociobehavioural traits seen in autism, including cognitive/medical complexities and attention deficit hyperactivity disorder (ADHD)3,4. We examined whole-genome sequencing data in cases of ASD (9,349) and controls (8,332) and identify 27 male individuals with ASD with X-chromosome microdeletions that implicate the long non-coding RNA PTCHD1-AS as an ASD-susceptibility gene (odds ratio = 2.56, P = 0.01). Two Ptchd1-as-knockout mouse models, which were created by disrupting/deleting the evolutionarily conserved exon 3, show ASD-like features in male mice, including increased repetitive behaviours and impaired social behaviour and communication without cognitive comorbidities or ADHD-like behaviours. Hippocampus-dependent synaptic function, complex learning and locomotor activity are unaffected in knockout mice. Native nuclear-enriched mouse Ptchd1-as showed sustained expression from postnatal day 7 onwards in the dorsal striatum, a predominantly GABAergic brain region that is implicated in ASD5. Multi-omics analysis revealed transcriptomic alterations in striatal oligodendrocytes, astrocytes and neurons impacting myelination and synaptic plasticity. Disrupting Ptchd1-as led to reductions in conventional protein kinase C (cPKC) isoforms, altered SRC and GSK-3α/β phosphorylation and enhanced striatal synaptic plasticity (long-term potentiation and long-term depression). Together, these findings implicate striatal molecular and circuit-level dysregulation through PTCHD1-AS in ASD aetiology.
- 13 May 2026
- Published by Springer Nature in Nature
- Vol. 655 (8122) , 418-428
Open AccessAn X-linked long non-coding RNA, PTCHD1-AS, and the core features of autism
There are around 100 genes or copy-number variations used in genetic testing for autism spectrum disorder (ASD)1,2. The established genes are protein coding, and the associated phenotypes usually extend beyond sociobehavioural traits seen in autism, including cognitive/medical complexities and attention deficit hyperactivity disorder (ADHD)3,4. We examined whole-genome sequencing data in cases of ASD (9,349) and controls (8,332) and identify 27 male individuals with ASD with X-chromosome microdeletions that implicate the long non-coding RNA PTCHD1-AS as an ASD-susceptibility gene (odds ratio = 2.56, P = 0.01). Two Ptchd1-as-knockout mouse models, which were created by disrupting/deleting the evolutionarily conserved exon 3, show ASD-like features in male mice, including increased repetitive behaviours and impaired social behaviour and communication without cognitive comorbidities or ADHD-like behaviours. Hippocampus-dependent synaptic function, complex learning and locomotor activity are unaffected in knockout mice. Native nuclear-enriched mouse Ptchd1-as showed sustained expression from postnatal day 7 onwards in the dorsal striatum, a predominantly GABAergic brain region that is implicated in ASD5. Multi-omics analysis revealed transcriptomic alterations in striatal oligodendrocytes, astrocytes and neurons impacting myelination and synaptic plasticity. Disrupting Ptchd1-as led to reductions in conventional protein kinase C (cPKC) isoforms, altered SRC and GSK-3α/β phosphorylation and enhanced striatal synaptic plasticity (long-term potentiation and long-term depression). Together, these findings implicate striatal molecular and circuit-level dysregulation through PTCHD1-AS in ASD aetiology.
- Open Access
Long-read genome sequencing increases genomic yield in congenital heart disease
Congenital heart disease (CHD) is the most common birth defect. We performed Illumina short-read genome sequencing (GS) of 1,101 probands, which identified a genetic cause in 16% of cases. We performed PacBio long-read GS in 43 genotype-elusive patients. Paired analysis revealed higher detection with long-read GS of single nucleotide variants, deletions, duplications, and insertions as well as fewer false-positives for indels and inversions. Long-read GS had higher coverage of nine CHD genes, but a low sequencing depth (de novo structural variant upstream of ZEB2 that was only resolved with long-read GS in a patient with extra-cardiac phenotype overlapping Mowat-Wilson syndrome. Long-read GS may provide an option in CHD patients who remain genotype-elusive on short-read GS.
Open AccessLong-read genome sequencing increases genomic yield in congenital heart disease
Congenital heart disease (CHD) is the most common birth defect. We performed Illumina short-read genome sequencing (GS) of 1,101 probands, which identified a genetic cause in 16% of cases. We performed PacBio long-read GS in 43 genotype-elusive patients. Paired analysis revealed higher detection with long-read GS of single nucleotide variants, deletions, duplications, and insertions as well as fewer false-positives for indels and inversions. Long-read GS had higher coverage of nine CHD genes, but a low sequencing depth (de novo structural variant upstream of ZEB2 that was only resolved with long-read GS in a patient with extra-cardiac phenotype overlapping Mowat-Wilson syndrome. Long-read GS may provide an option in CHD patients who remain genotype-elusive on short-read GS.
- Open Access
A validated heart-specific model for splice-disrupting variants in childhood heart disease
Congenital heart disease (CHD) is the most common congenital anomaly. Non-canonical splice-disrupting variants are not routinely evaluated by clinical tests. Algorithms including SpliceAI predict such variants, but are not specific to cardiac-expressed genes. Whole genome (WGS) (n=1083) and myocardial RNA-Sequencing (RNA-Seq) (n=114) of CHD cases was used to identify splice-disrupting variants. Using features of variants confirmed to affect splicing in myocardial RNA, we trained a machine learning model that outperformed SpliceAI for predicting cardiac-specific splice-disrupting variants (AUC 0.92 vs 0.66), and was independently validated in 43 cardiomyopathy probands (AUC 0.88 vs 0.64). Application of this model to 971 CHD WGS samples identified 9% patients with splice-disrupting variants in CHD genes. Forty-one% of predicted splice-disrupting variants were deeply intronic. The burden of variants in CHD genes was higher in cases compared with 2,570 controls. Our model improved genetic yield by identifying splice-disrupting variants that are not evaluated by routine tests.
Open AccessA validated heart-specific model for splice-disrupting variants in childhood heart disease
Congenital heart disease (CHD) is the most common congenital anomaly. Non-canonical splice-disrupting variants are not routinely evaluated by clinical tests. Algorithms including SpliceAI predict such variants, but are not specific to cardiac-expressed genes. Whole genome (WGS) (n=1083) and myocardial RNA-Sequencing (RNA-Seq) (n=114) of CHD cases was used to identify splice-disrupting variants. Using features of variants confirmed to affect splicing in myocardial RNA, we trained a machine learning model that outperformed SpliceAI for predicting cardiac-specific splice-disrupting variants (AUC 0.92 vs 0.66), and was independently validated in 43 cardiomyopathy probands (AUC 0.88 vs 0.64). Application of this model to 971 CHD WGS samples identified 9% patients with splice-disrupting variants in CHD genes. Forty-one% of predicted splice-disrupting variants were deeply intronic. The burden of variants in CHD genes was higher in cases compared with 2,570 controls. Our model improved genetic yield by identifying splice-disrupting variants that are not evaluated by routine tests.